Yale Jen
Stock Analyst at Laidlaw & Co.
(0.05)
# 4,185
Out of 4,829 analysts
15
Total ratings
14.29%
Success rate
-45.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICAD iCAD, Inc. | Downgrades: Hold | n/a | $3.60 | - | 1 | Apr 17, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $76.76 | +36.79% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.99 | +111.35% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $1.37 | +629.93% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $6.68 | +618.56% | 1 | Jul 29, 2024 | |
| MEIP MEI Pharma | Downgrades: Hold | n/a | $2.05 | - | 1 | Jul 23, 2024 | |
| AFMD Affimed | Maintains: Buy | $15 → $25 | $0.69 | +3,549.64% | 1 | Jun 13, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.52 | +4,744.96% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $7.5 | $0.16 | +4,664.93% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.01 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.81 | +1,127.14% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.81 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $1.64 | +14,522.56% | 1 | Sep 6, 2022 |
iCAD, Inc.
Apr 17, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.60
Upside: -
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $76.76
Upside: +36.79%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.99
Upside: +111.35%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $6.68
Upside: +618.56%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.05
Upside: -
Affimed
Jun 13, 2024
Maintains: Buy
Price Target: $15 → $25
Current: $0.69
Upside: +3,549.64%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.52
Upside: +4,744.96%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $7.5
Current: $0.16
Upside: +4,664.93%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.01
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.81
Upside: +1,127.14%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.81
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.64
Upside: +14,522.56%